Leo Shrugs Off Timber Drug Failure As Revenues Roar

The Danish firm’s dermatology products have made significant strides in the past six months, leading to an upwards revision of its sales forecast for full-year 2024.

Leo logo
• Source: Leo Pharma

More from Earnings

More from Business